Stacey S Degarmo - FDA Investigator Report

Designation: Regulatory Officer

Duty Station: Silver Spring MD 20993-0002

Organizations: DHHS FDA CDER OMPT CDER OC OMQ DDQI GCBI

Overview Statistics

88
Total Inspections
58
Total 483s Issued
0
Warning Letters Issued

Inspection Details

Longest Inspection: 43 days
Shortest Inspection: 1 days
Average Length: 5.0 days

Discover the bigger picture. This is just the tip of the iceberg.

Gain access to comprehensive analysis, detailed reports, AI assistant, and much more.

Schedule a Demo

Stacey S Degarmo's Recent Inspections

DateCompanyCityCountryFEI Number483
2016-09-30Wyeth BioPharma Division of Wyeth Pharmaceuticals LLCAndoverUnited States1222181
2016-08-26Lonza Biologics, Inc.PortsmouthUnited States3001451441
2016-07-13Curia Massachusetts, Inc.BurlingtonUnited States3002951540
2016-06-15Avista Pharma Solutions, Inc.AgawamUnited States1220785
2016-05-24Lantheus Medical Imaging, Inc.North BillericaUnited States1216602
2016-04-27AstraZeneca LPWestboroughUnited States1220331
2016-03-25Cambridge Isotope Laboratories, Inc.AndoverUnited States1000513287
2016-02-19Anderson Holdings Inc.NashuaUnited States3011859261
2015-08-28Mytilini Enterprises LLC dba Bedford Pharmacy Inc.BedfordUnited States3003687986
2015-07-15Dyax Corp.BurlingtonUnited States3007220955

Sign Up to get the complete report.

Download 483s and EIRs for Stacey S Degarmo

Stacey S Degarmo - Co-Inspectors

Stacey S Degarmo's Active Locations

  • United States
  • India
  • Canada
  • Denmark
  • Belgium
  • Malta

Stacey S Degarmo's Year-wise Inspection Count

  • 2009:15 inspections
  • 2010:12 inspections
  • 2011:12 inspections
  • 2012:12 inspections
  • 2013:10 inspections
  • 2014:10 inspections
  • 2015:9 inspections
  • 2016:8 inspections
Last Updated: 2025-05-14 06:11:22